Table 2.
MANCOVA Results for Cut-Score Models on PFS-R and PFS-12
| Cut-Score Models: PFS-R | F Values | ||||||
|---|---|---|---|---|---|---|---|
| Model | None | Mild | Mod | Severe | Pillai's Trace |
Wilk's Lambda |
Hotelling's Trace |
| D | 0 | 1–2 | 3–5 | 6–10 | 33.19 | 40.70 | 48.32 |
| A | 0 | 1–3 | 4–6 | 7–10 | 32.65 | 39.46 | 46.25 |
| C | 0 | 1–3 | 4–7 | 8–10 | 31.21 | 37.59 | 43.97 |
| E | 0 | 1–2 | 3–6 | 7–10 | 28.47 | 33.28 | 37.94 |
| B | 0 | 1–4 | 5–7 | 8–10 | 26.03 | 30.32 | 34.50 |
| Cut-Score Models: PFS-12 | F Values | ||||||
| Model | None | Mild | Mod | Severe |
Pillai's Trace |
Wilk's Lambda |
Hotelling's Trace |
| D | 0 | 1–2 | 3–5 | 6–10 | 34.68 | 42.87 | 51.22 |
| A | 0 | 1–3 | 4–6 | 7–10 | 33.33 | 40.59 | 47.89 |
| C | 0 | 1–3 | 4–7 | 8–10 | 31.82 | 38.46 | 45.10 |
| E | 0 | 1–2 | 3–6 | 7–10 | 29.56 | 34.97 | 40.27 |
| B | 0 | 1–4 | 5–7 | 8–10 | 27.36 | 32.13 | 36.81 |
(Models Adjusted for disease stage, type of therapy, tamoxifen use, antidepressant use, number of comorbid conditions that limit activities, age, race, and education [N=857])